Doctor profile · Federal record
Dr. Katherine Sandstrom, NP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Family Nurse Practitioner · Portland, OR
- NPI 1982973095
- Accepts Medicare
- 16 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
541 Ne 20Th Ave Ste 210
Portland, OR 97232
(503) 233-6940 - Additional location
-
19075 Nw Tanasbourne Dr, Suite 200
Hillsboro, OR 971245860
(503) 684-8252
fax (503) 684-8252 - Additional location
-
5005 Ne Sandy Blvd
Portland, OR 972131941 - Mailing address
-
800 Sw 13Th Ave
Portland, OR 972051902
Credentials & registration
- NPI registered
- December 2011 — 15 yrs on file
- Profile last updated
- March 24, 2021
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State licenses (2)
- Oregon #201250094NP · New Jersey #26NJ00353200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982973095. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
618
Distinct HCPCS
10
Medicare allowed
$39,293
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 131 | 27 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 117 | 83 | $78 | |
11102 |
Biopsy of related skin growth, first growth | 89 | 75 | $84 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 72 | 56 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 59 | 32 | $46 | |
17000 |
Destruction of precancer skin growth, 1 growth | 58 | 47 | $36 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 32 | 32 | $98 | |
17110 |
Destruction of skin growth, 1-14 growths | 22 | 21 | $99 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 14 | 14 | $137 | |
11104 |
Punch biopsy, first skin growth | 13 | 13 | $114 |
In context: peer comparison
Among 97 peers in Portland Family Nurse Practitioner, average services per provider: 1,896. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$1,481
Transactions
63
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 22 | $503.92 | |
| Janssen Biotech, INC. | 11 | $289.30 | |
| Pfizer INC. | 7 | $236.97 | |
| Lilly USA, LLC | 12 | $208.81 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $166.61 | |
| Genzyme Corporation | 1 | $35.89 | |
| Incyte Corporation | 1 | $24.97 | |
| Arcutis Biotherapeutics, INC. | 1 | $14.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
485
Patients
294
Total drug cost
$75,514
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 76 | 59 | $528 |
| Doxycycline Monohydrate | Generic | 68 | 29 | $3,001 |
| Clobetasol Propionate | Generic | 48 | 33 | $1,939 |
| Mupirocin | Generic | 46 | 43 | $371 |
| Ketoconazole | Generic | 42 | 31 | $1,475 |
| Spironolactone | Generic | 37 | 0 | $1,277 |
| Fluorouracil | Generic | 34 | 32 | $2,896 |
| Hydrocortisone | Generic | 33 | 32 | $287 |
| Tacrolimus | Generic | 28 | 22 | $3,054 |
| Minoxidil | Generic | 23 | 0 | $259 |
Frequently asked questions
What is Dr. Katherine Sandstrom's medical specialty?
Dr. Katherine Sandstrom practices Family Nurse Practitioner in Portland, OR.
Where does Dr. Katherine Sandstrom practice?
Dr. Katherine Sandstrom practices at 541 Ne 20Th Ave Ste 210, Portland, OR 97232. Office phone: 5032336940.
What is Dr. Katherine Sandstrom's NPI?
Dr. Katherine Sandstrom's National Provider Identifier (NPI) is 1982973095, issued by NPPES.
Does Dr. Katherine Sandstrom accept Medicare assignment?
Yes. Dr. Katherine Sandstrom accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katherine Sandstrom commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.